Pharmacist Suspended for Unsafe Remote Prescribing of High-Risk Medicines
Date of Decision: August 28, 2025
Registrant's Role: Pharmacist
Allegations:
- Prescribed over 3,000 high-risk prescriptions through online pharmacies without proper clinical assessments.
- Relied solely on online questionnaires without face-to-face or virtual consultations.
- Failed to access GP or specialist records, compromising patient safety.
- Issued prescriptions for controlled drugs (e.g., opioids, z-drugs) inappropriately and without due consideration of dependence or misuse.
- Approved repeat prescriptions for patients with signs of drug-seeking behaviour.
- Failed to refer patients to their GPs or implement safety netting.
- Demonstrated a transactional approach to prescribing rather than one based on clinical need or UK prescribing guidance.
Outcome: Four-month suspension with a review; immediate interim suspension ordered.
GPhC Standards Breached:
- Standard 1 β Person-centred care: Failed to put the care of individuals first by not conducting appropriate assessments.
- Standard 2 β Partnership working: Did not collaborate with GPs or other professionals.
- Standard 4 β Professional judgement: Exercised poor judgment in issuing high-risk medications based solely on questionnaires.
- Standard 6 β Communication: Did not engage in any form of meaningful patient communication or follow-up.
- Standard 7 β Confidentiality and privacy: Failed to properly safeguard patient data and history by neglecting to access GP records.
- Standard 8 β Speaking up about concerns: Did not challenge unsafe prescribing models or raise concerns.
- Standard 9 β Leadership: Did not act as a responsible professional despite having the autonomy to make prescribing decisions.
Case Summary
Allegations
This case concerned serious concerns about a pharmacist’s practice in online prescribing roles at two remote pharmacies: Instant E-Care Ltd and UK Meds Online Ltd. Between May 2019 and January 2020, the registrant issued a combined total of over 4,300 prescriptions, including high-risk medicines such as opioids (codeine, dihydrocodeine), z-drugs (zopiclone, zolpidem), modafinil, antidepressants (sertraline, citalopram), and other medications requiring ongoing monitoring.
Allegations centred on the registrant’s over-reliance on online questionnaires, lack of any virtual or in-person consultations, failure to verify medical histories, and failure to contact patientsβ GPs. The prescribing was done in a transactional manner, often in the absence of any safety netting or professional judgment grounded in established clinical guidance.
Continue Reading the Full Case
Create a free account or log in to access the complete case summary.
- Full allegations considered by the GPhC
- Panel findings and reasoning
- Outcome of the investigation
- Sanctions considered and imposed on the Pharmacist
- Key professional learning points
Original Case Document
View the Full Determination Document
The original determination transcript is available to registered users.
- Download the official GPhC determination
- Full hearing transcript
- Detailed findings of fact
- Sanction reasoning
- Details of the pharmacy professionals involved
